Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nafazatrom: may support remission in patients with thrombotic thrombocytopenic purpura

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Nafazatrom: may support remission in patients with thrombotic thrombocytopenic purpura. Inpharma Wkly. 528, 6 (1986). https://doi.org/10.1007/BF03298926

    Download citation

    Keywords

    • Platelet Count
    • Purpura
    • Fresh Freeze Plasma
    • Thrombotic Thrombocytopenic Purpura
    • Plasma Infusion